Author： Remme Willem
Publisher： Springer Publishing Company
ISSN： 0920-3206
Source： Cardiovascular Drugs and Therapy, Vol.25, Iss.2, 2011-04, pp. : 109-110
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
LOX-1: A New Target for Therapy for Cardiovascular Diseases
Cardiovascular Drugs and Therapy, Vol. 25, Iss. 5, 2011-10 ,pp. :
Access to resources
Recommend
New Vectors and Strategies for Cardiovascular Gene Therapy
Current Gene Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. :
Innovative Companies in Cardiovascular Therapy
Pharmaceutical Innovation, Vol. 12, Iss. 2, 2003-02 ,pp. :
Gene therapy for cardiovascular diseases
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. :
Gene therapy for cardiovascular diseases
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. :